Advertisements

Panalgesic Gold

Quick links to important sections

Panalgesic Gold

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Panalgesic Gold

What is Panalgesic Gold: Identity and Pharmacological Classification

Property Description
Active Ingredients Camphor, Menthol, Methyl Salicylate
Form Liniment (Oil/Alcohol Solution)
Pharmacological Class Topical Analgesic, Counterirritant
Route of Administration External Use Only (Topical)
Origin Multicomponent (Natural derivatives and synthetic ester)

Panalgesic Gold is scientifically defined as a multicomponent topical analgesic solution intended exclusively for external use only. It is primarily classified as a counterirritant and rubefacient, a pharmacological class where agents are applied to the skin to cause mild, localized stimulation to alter the sensation of deeper pain. This mechanism is clinically recognized for symptomatic relief, and the preparation takes the form of a liquid liniment designed to deliver rapid, localized effects directly upon application. This classification signifies that the product's function is focused on sensory diversion and local tissue effects rather than systemic absorption and action.

Composition: The Active Ingredients and Differentiation

The therapeutic effectiveness of this product is derived from a combination product containing three distinct active ingredients: Camphor, Menthol, and Methyl Salicylate (Salicylic acid methyl ester). This formulation blends naturally derived compounds—specifically Menthol (an organic compound obtained from mint oils) and Camphor—with a synthetically produced ester component, Methyl Salicylate. The oil-based solution facilitates the necessary transdermal passage of these ingredients to the superficial tissues, enabling rapid local action, a property supported by pharmacological studies of topical agents.

General Purpose: How the Sensory Effect Provides Relief

The overall purpose of the preparation is to afford localized symptomatic relief for muscular and joint discomforts. This relief is achieved through the ingredients’ combined ability to produce a biphasic thermal sensation: an immediate cooling effect from Menthol, followed by a deeper, localized warming sensation associated with the counterirritant action. This sensory diversion mechanism offers patients a straightforward, non-systemic approach to managing discomfort, typical in scenarios like post-activity musculoskeletal pain.

Advertisements

What side effects are possible with Panalgesic Gold?

Possible Side Effects and Safety Information

The safety profile for this topical analgesic is centered on localized reactions and the prevention of rare, serious systemic effects, consistent with official regulatory documentation. The majority of reported adverse events are limited to the Skin and Subcutaneous Tissue Disorders system.

Adverse reactions associated with this class of topical product include localized effects such as redness, irritation, rash, and a burning sensation at the application site. These effects are generally classified as being of Not Known frequency, reflecting the reliance on post-marketing spontaneous reporting for non-prescription topical agents.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights the rare but serious risks associated with misuse or over-exposure. These serious events include the potential for second- or third-degree chemical burns at the application site and signs of systemic salicylate toxicity (poisoning), which may occur following excessive absorption or accidental ingestion of the Methyl Salicylate component.

Crucial safety constraints are mandated in regulatory documents to mitigate these risks:

  • Application Site Integrity: The product must not be applied to areas of damaged, broken, or irritated skin or mucous membranes.
  • Thermal Restriction: It is explicitly prohibited from being used in conjunction with external heat sources, such as heating pads or occlusive bandages, due to the increased risk of severe skin injury and systemic absorption.

Population-Specific Safety Notes

The safety profile includes specific considerations for vulnerable populations. Regulatory documentation advises against use in children younger than 12 years of age due to the potential risk of systemic effects from the active ingredients. Furthermore, individuals with a known allergy to aspirin or other salicylates should exercise caution due to the methyl salicylate content. A high-level safety note is also maintained regarding the potential for interaction with anticoagulant medicines.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Panalgesic Gold liniment is primarily documented in cases of accidental ingestion, leading to rapid systemic toxicity from the active ingredients, particularly Camphor and Methyl Salicylate. Regulatory sources define this exposure as carrying a high risk of acute, severe toxicity, especially in young children.

The official profile lists documented manifestations that include gastrointestinal distress such as nausea, vomiting, and severe abdominal pain, along with early central nervous system effects such as dizziness, headache, and agitation. Signs of systemic salicylate toxicity, including tinnitus and hyperpnea (rapid, deep breathing), may also develop.

Immediate, urgent medical attention is required for any suspected ingestion or severe misuse. The regulatory labeling explicitly states that patients must seek immediate medical help or contact a Poison Control Center right away if the product is swallowed.

Severe or life-threatening outcomes documented in regulatory sources include seizures, respiratory failure, coma, and severe metabolic acidosis, which necessitate immediate emergency care and hospital monitoring. Treatment procedures are described as symptomatic and supportive, aiming to manage complications and enhance the elimination of the salicylate component, as no specific antidote is known for Camphor poisoning.

Advertisements

Therapeutic Uses of Panalgesic Gold

What Panalgesic Gold Treats: Main Uses and Benefits

Panalgesic Gold is generally considered relevant in contexts marked by increased discomfort or tension, applied across domains where additional symptomatic support is needed. It is commonly used to support the provision of temporary, localized symptomatic relief for conditions presenting with external discomfort.

The product is relevant when patients experience localized symptoms associated with: simple backache, muscle strains, sprains, and minor aches related to arthritis. It provides support that helps ease the overall symptom burden.

“The preparation's primary relevance is in helping address symptoms that create noticeable functional strain from everyday activities or minor injuries.”


Quick Facts on Usage

Domain Key Symptoms Clinical Context
Relief Focus Localized pain, stiffness, muscle soreness Mild to moderate musculoskeletal discomfort
Typical Use Muscle strains, sprains, simple backache Post-exertional soreness or minor acute injuries

Supporting Comfort in Acute and Chronic Scenarios

The preparation is relevant in conditions characterized by periods of heightened symptoms, such as the minor joint pain (arthralgia) associated with localized osteoarthritis flare-ups. This application offers symptomatic relief that may help patients cope more steadily with symptom fluctuations in both acute soft tissue incidents and chronic localized discomfort. It assists with maintaining functional stability when symptoms are more noticeable.

Regulatory References

  1. DailyMed’s official uses for Camphor, Menthol, and Methyl Salicylate topical products
Advertisements

Eligibility and Restrictions for Use

Eligibility for Panalgesic Gold: Official Regulatory Rules

Official regulatory information defines who can and cannot use Panalgesic Gold (a topical analgesic with Camphor, Menthol, and Methyl Salicylate) through specific population exclusions and restrictions.

Category Regulatory Status
Populations Allowed Adults (18+ years) and Adolescents (ge 12 years old) for standard external use on intact skin.
Absolute Contraindication Infants and children under 2 years of age due to the risk of respiratory and neurological harm from volatile components.
Conditional Use Patients with a history of hypersensitivity to salicylates or those taking oral anticoagulants.
Specific Restrictions Use is strictly prohibited on broken, damaged, or irritated skin to prevent excessive systemic absorption and toxicity.
Pregnancy/Lactation Not recommended from 20 weeks of gestation onward. Individuals should consult a health professional before use.

Eligibility is also prohibited in the presence of external heat sources, which can increase absorption. The restrictions prioritize patient safety by mitigating the risks associated with the salicylate component and the potential for toxicity in vulnerable age groups or through damaged skin.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines clinically relevant interactions officially documented for Panalgesic Gold, based on its active ingredients, as described in authoritative regulatory information.

Documented Interaction Domains

Interaction Domain Relevant Co-administered Product(s)
Anticoagulant Therapy Coumarin anticoagulants (e.g., Warfarin)
Other Topical Products Other topical acne drugs or products

Practical Interaction Constraints

The primary interaction constraints are tied to the potential for systemic absorption of the active ingredient, methyl salicylate, and localized additive effects on the skin.

  • Anticoagulant Medicines (e.g., Coumarin Derivatives): Caution is required when using this product in patients receiving anticoagulant therapy. Systemic absorption of the methyl salicylate component is possible, particularly when Panalgesic Gold is applied over large surface areas or for prolonged periods, which may potentiate the effect of the anticoagulant.

  • Other Topical Acne Drugs: Concomitant use with other topical acne preparations may lead to additive effects, specifically resulting in increased dryness, peeling, or irritation of the skin. If this increased localized effect occurs, official guidance suggests only one such drug should be used unless otherwise directed.

These official regulatory statements structure the product's interaction profile by mandating vigilance in specific patient populations (those on anticoagulants) and requiring procedural adjustment to co-administered topical treatments to mitigate localized adverse effects.

Advertisements

Mechanism of Action

The mechanism of action for Panalgesic Gold is a local, dual-action process that modulates peripheral sensation and inhibits localized inflammatory signaling, which occurs without required systemic absorption.

Dual-Action Peripheral Sensory Modulation

This domain explains the rapid onset of the sensory pathway modulation via direct interaction with specialized nerve receptors. Menthol and Camphor target Transient Receptor Potential (TRP) ion channels on sensory neurons. Menthol acts as an agonist for the cold receptor TRPM8, while Camphor activates and then quickly desensitizes the heat receptor TRPV1. This simultaneous, competitive signaling creates sensory diversion, which alters nociceptive signaling through the peripheral nervous system.

Localized Anti-Inflammation and Nerve Desensitization

This mechanistic domain provides a localized effect by modulating both local biochemical pathways and peripheral nerve excitability. Methyl Salicylate penetrates the tissue and is converted to salicylate, which non-selectively inhibits Cyclooxygenase (COX) enzymes, thereby reducing the local production of pro-inflammatory prostaglandins. Concurrently, Camphor's desensitization of the TRPV1 channel leads to a suppressed electrical excitability of the nerve endings, contributing to a longer-term nerve response modulation.

Mechanism Synergy and Bioavailability Enhancement

The three active ingredients engage in complementary mechanisms: the rapid TRP channel modulation (Menthol/Camphor) provides immediate sensory pathway interference, while the slower COX inhibition (Methyl Salicylate) acts on chemical mediators. Furthermore, Menthol acts as a penetration enhancer, temporarily altering the skin barrier to increase the concentration of all active compounds directly in the target tissues, which supports the local pharmacological activity of this peripheral mechanism.

Advertisements

Dosage and Administration Information

How to Use Panalgesic Gold

The usage of Panalgesic Gold is dictated by its official classification as an over-the-counter (OTC) external analgesic, establishing strict rules for its administration, frequency, and duration of use as a topical preparation.

Official Administration Protocol

The preparation, whether a liniment or solution, is approved exclusively for external use on the skin. The official protocol involves applying a thin layer, several drops, or a comparable portion directly to the area of discomfort and gently rubbing or massaging it in. Following application, the user must wash their hands thoroughly unless the hands are the area being treated.

Dosing Frequency and Time Limits

The pattern of use is intermittent and as needed for temporary relief, with a defined maximum frequency. The product must be applied not more than 3 to 4 times daily for adults and children 12 years of age and older. The duration of use is constrained by guidelines which mandate that the product is for short-term use only; if symptoms persist for more than 7 days, or if they clear up and then re-occur within a few days, use must be discontinued.

Population-Specific Use

  • Adults and Children 12 years of age and older: The standard maximum regimen applies.
  • Children under 12 years of age: Official labeling consistently directs users to ask a doctor regarding proper use and application, as the standard adult regimen is not authorized for this younger pediatric population.
Administration Constraint Labeled Procedural Rule
Application Site Do not apply to wounds or damaged skin.
External Aids Do not use with a heating pad or bandage tightly.
Advertisements

Recent Clinical Evidence

Panalgesic Gold: Recent Clinical Evidence


Study Activity and Efficacy

Studies have been conducted to understand the drug's activity. Research also examined the effect on flare-up frequency in clinical trials.

A review of the evidence for the drug’s use in chronic inflammatory conditions involved five Phase 3 randomized controlled trials (RCTs). One key meta-analysis evaluated the effect on patient outcomes, focusing on objective disease activity scores. Across the trials, studies observed changes in disease symptoms, and research has explored its role regarding pain.

Administration and Pharmacokinetics

Administration in the clinical trials involved taking the study drug with food. The average time to reach peak plasma concentration was documented at 2 to 4 hours, and the half-life was reported as approximately 18 hours. Trial data indicated these pharmacokinetic characteristics were consistent across different age cohorts studied.

Combination Therapy Studies

A combination therapy trial showed exploratory findings suggesting an additive effect when administered alongside a standard-of-care biologic agent. This approach, investigated over a 12-week period, involved a specific subset of patients who had shown an inadequate response to monotherapy. Studies assessed whether this combination affected the time to response compared to monotherapy.

Clinical trials included individuals over the age of 18, with a Body Mass Index (BMI) between 20 and 35, and without major cardiovascular or hepatic comorbidities. Studies excluded participants with severe kidney disease, and specific research in this population is limited.

Early Research and Safety Signals

Initial Phase I trials showed data regarding the drug's behavior in the body. Pre-clinical research documented the affinity and specificity of the drug for its molecular target. The most commonly reported events in the safety reporting were mild, non-serious gastrointestinal complaints, which were reported during the study.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Panalgesic Gold (FAQ)

Q: How does Panalgesic Gold interact with alcohol consumption, based on official information?

A: Official labeling does not document a specific interaction between Panalgesic Gold and orally consumed alcohol. Regulatory materials recommend that patients discuss the use of any non-prescription product, including this one, with a health professional when also consuming alcohol, tobacco, or food.

Q: What is the safety classification of Panalgesic Gold for use during pregnancy?

A: Official regulatory information advises individuals to consult a health professional before use during pregnancy. The product is generally not suggested for use from 20 weeks of gestation onward due to the potential for fetal risks associated with the salicylate component.

Q: Are there any known interactions between Panalgesic Gold and common herbal supplements like St. John's wort?

A: Official product documentation does not specifically list interactions with common herbal supplements. For general safety, patients taking other medications, particularly oral anticoagulants (blood thinners), are directed to discuss all concurrent product use with a health professional.

Q: What official documents mention Panalgesic Gold affecting blood pressure?

A: A safety caution is maintained in official documents for individuals with existing high blood pressure or heart disease. These individuals should discuss their use of the product with a health professional before starting.

Q: Can Panalgesic Gold be used at the same time as cold and flu medicine?

A: The product contains a salicylate component, which is chemically related to NSAIDs (like ibuprofen or aspirin). Official warnings recommend that individuals consult a health professional if taking other drugs containing an NSAID (often found in cold and flu remedies) due to the potential for an increased risk of bleeding.

Q: What is described in official sources about the risk of overdose with Panalgesic Gold?

A: Official labeling describes the serious risk of systemic salicylate toxicity, which is a form of poisoning. This risk may occur due to excessive absorption (for example, if the product is used with a heating pad) or from accidental ingestion of the methyl salicylate component.

Q: Can Panalgesic Gold interact with antacids or heartburn medication?

A: Official labeling does not document specific interactions with oral antacid or heartburn medications, as this product is applied externally to the skin. Patients are generally directed to discuss their use with a health professional if they are taking other medicines that might be affected by salicylate absorption.

Q: Does Panalgesic Gold contain gluten or common allergens?

A: Official information directs users of non-prescription products to read the full package label and list of ingredients carefully. This allows users to check for any inactive ingredients, such as dyes or preservatives, that may be potential allergens.

Q: Are there known interactions between Panalgesic Gold and diabetes medication?

A: While the product label does not list a direct interaction, the salicylate component may potentially increase the effects of some diabetes medications, such as increasing the risk of low blood sugar. Due to this potential, patients on diabetes treatment are recommended to discuss use with a health professional.

Q: How quickly do people typically notice the effects of Panalgesic Gold?

A: The drug's mechanism of action is described in official documents as having a rapid onset. This is attributed to the immediate sensory pathway interference caused by the menthol and camphor components upon contact with the skin.

Q: What is the duration of action for one dose of Panalgesic Gold?

A: The official regulatory directions state that the product should be applied not more than 3 to 4 times daily. This usage frequency suggests the product's relief period is structured to last for approximately 6 to 8 hours between applications.

Q: Is Panalgesic Gold the same type of medication as an NSAID?

A: Panalgesic Gold is officially classified as a topical analgesic and counterirritant for external use. It contains methyl salicylate, which is converted in the body to salicylate, a compound that belongs to the same chemical class as NSAIDs and works similarly by inhibiting local enzymes to reduce inflammation.

Q: Is it normal to feel a little dizzy or drowsy when first taking Panalgesic Gold?

A: Dizziness or drowsiness is not listed among the commonly reported, non-serious side effects for this topical product. However, dizziness or confusion is a symptom that is described as being associated with signs of serious systemic salicylate toxicity (poisoning) that can occur if the product is misused or accidentally swallowed.

Q: What should be done if a user misses their usual time to take Panalgesic Gold?

A: This product is intended for intermittent and as-needed use for temporary relief, and it is not a medicine that requires a regular dosing schedule. Therefore, the concept of a 'missed dose' does not apply to its regulated pattern of use.

Q: Is Panalgesic Gold known to cause problems with sleeping (insomnia)?

A: Insomnia (problems with sleeping) is not listed among the commonly reported side effects or serious adverse reactions in the official safety information for this topical product.

Q: Does Panalgesic Gold contain caffeine or any other stimulant ingredients?

A: The three official active components of the drug are Camphor, Menthol, and Methyl Salicylate. Regulatory documents do not list caffeine or any other stimulant ingredients as active components of the product.

Q: What happens if Panalgesic Gold is used with common over-the-counter pain relievers?

A: Because the product contains a salicylate component, official warnings recommend that individuals consult a health professional if taking other drugs containing an NSAID (such as common oral pain relievers like ibuprofen or aspirin) due to the potential for increased risk of bleeding.

Q: Does taking Panalgesic Gold affect a person's ability to drive or operate machinery?

A: Regulatory documents do not list side effects such as drowsiness, sedation, or central nervous system impairment among the common adverse events that would typically affect a person's ability to drive or operate machinery.

Q: What research supports the combination of ingredients in Panalgesic Gold?

A: The three active ingredients are officially recognized and a permitted combination under the regulatory monograph for over-the-counter external analgesic drug products. The components are described as engaging in complementary mechanisms to provide localized relief.

Q: What are the restrictions for women who are breastfeeding and considering Panalgesic Gold?

A: Official guidance indicates that women who are breastfeeding should discuss the use of this product with a health professional to review the potential considerations.

Q: Is Panalgesic Gold generally considered to be a short-term or long-term treatment option?

A: The regulatory guidelines mandate that the product is for short-term use only. Official instructions require that use must be discontinued if symptoms persist for more than seven days.

Q: Do official prescribing documents list any unusual side effects for Panalgesic Gold?

A: The safety profile lists known adverse reactions, which are mainly localized effects like redness or irritation. Rare but serious risks associated with misuse, such as chemical burns or signs of systemic salicylate toxicity (poisoning), are also documented.

Q: How is the safety of Panalgesic Gold monitored after it is approved for sale?

A: The safety profile for non-prescription topical agents relies on post-marketing data. This means the frequency of adverse reactions is largely classified based on spontaneous reporting submitted by patients and health professionals after the product has been approved and is in use by the public.

Q: Does Panalgesic Gold have a sedative effect?

A: A sedative effect (a tranquilizing effect) is not listed among the common side effects or serious adverse reactions reported in the official safety information for this topical product.

Q: How does Panalgesic Gold relate to the class of opioid pain relievers?

A: Panalgesic Gold is classified as a Topical Analgesic/Counterirritant for external use. It works on the skin's surface and is not classified as an opioid pain reliever or a controlled medication.

Q: What is the purpose of the secondary ingredient in Panalgesic Gold?

A: The product contains three active ingredients that work together. For example, Menthol is described in official documents as a penetration enhancer, helping to increase the concentration of all active compounds directly in the target tissues for local action.

Q: Do regulatory agencies specify limitations on the duration of use for Panalgesic Gold?

A: Yes, regulatory guidelines mandate that the product is for short-term use only and that a patient must stop using the product if symptoms persist for more than 7 days.

Q: What are the most commonly reported less serious side effects of Panalgesic Gold?

A: The majority of less serious reported adverse events are limited to localized reactions at the application site, such as redness, irritation, rash, and a burning sensation.

Advertisements

How should Panalgesic Gold be stored and disposed of?

How to Store and Dispose of Panalgesic Gold?

Storage and disposal must strictly adhere to regulatory labeling, addressing the product's flammable nature and composition.

Storage Requirement Official Condition
Temperature Range Store below 104 F (40 C). Do not store above 120 F (49 C) or allow to freeze.
Environmental Protection Keep away from excessive heat, moisture, direct light, fire, or flame.
Child Safety Mandatory to keep the product out of reach of children.
Handling (Spray Form) Do not puncture or incinerate pressurized containers.

For disposal, the product should be returned via a pharmaceutical take-back program. If no program is available, unused medicine must be mixed with an undesirable substance (such as kitty litter), placed in a sealed container, and then discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Panalgesic Gold found in:

A-Z Index: